<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3427312/" ref="ordinalpos=2553&amp;ncbi_uid=4201555&amp;link_uid=PMC3427312" image-link="/pmc/articles/PMC3427312/figure/pone-0043874-g008/" class="imagepopup">Figure 8. Schematic representation of the possible mechanism of BBR on the S1P2 receptor..  From: Berberine Reduces Fibronectin Expression by Suppressing the S1P-S1P2 Receptor <span class="highlight" style="background-color:">Pathway</span> in Experimental Diabetic Nephropathy Models. </a></div><br /><div class="p4l_captionBody">Subjecting GMCs to HG results in the activation of NF-<b>κ</b>B signaling pathway, and thus up-regulates S1P2 receptor expression, which contributes to the increased FN levels. In contrast, pretreatment with BBR inhibits S1P2 receptor and FN levels possibly by down-regulating NF-<b>κ</b>B activation.</div></div>